These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 8774518)

  • 1. Failure of pulse intravenous methylprednisolone treatment in juvenile dermatomyositis.
    Lang B; Dooley J
    J Pediatr; 1996 Mar; 128(3):429-32. PubMed ID: 8774518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term prognosis of patients with juvenile dermatomyositis initially treated with intravenous methylprednisolone pulse therapy.
    Huang JL
    Clin Exp Rheumatol; 1999; 17(5):621-4. PubMed ID: 10544850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of early treatment of severe juvenile dermatomyositis with intravenous methylprednisolone and methotrexate.
    Al-Mayouf S; Al-Mazyed A; Bahabri S
    Clin Rheumatol; 2000; 19(2):138-41. PubMed ID: 10791626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulse Dose Methylprednisolone Therapy for Adult Idiopathic Inflammatory Myopathy.
    Raghu P; Manadan AM; Schmukler J; Mathur T; Block JA
    Am J Ther; 2015; 22(4):244-7. PubMed ID: 25490616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medications received by patients with juvenile dermatomyositis.
    Kishi T; Bayat N; Ward MM; Huber AM; Wu L; Mamyrova G; Targoff IN; Warren-Hicks WJ; Miller FW; Rider LG;
    Semin Arthritis Rheum; 2018 Dec; 48(3):513-522. PubMed ID: 29773230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of pulse corticosteroid therapy for juvenile dermatomyositis.
    Paller AS
    Pediatr Dermatol; 1996; 13(4):347-8. PubMed ID: 8844758
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacokinetic study of oral prednisolone compared with intravenous methylprednisolone in patients with juvenile dermatomyositis.
    Rouster-Stevens KA; Gursahaney A; Ngai KL; Daru JA; Pachman LM
    Arthritis Rheum; 2008 Feb; 59(2):222-6. PubMed ID: 18240180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of pemphigus vulgaris with brief, high-dose intravenous glucocorticoids.
    Werth VP
    Arch Dermatol; 1996 Dec; 132(12):1435-9. PubMed ID: 8961871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of chronic inflammatory demyelinating polyneuropathy with high-dose intermittent intravenous methylprednisolone.
    Lopate G; Pestronk A; Al-Lozi M
    Arch Neurol; 2005 Feb; 62(2):249-54. PubMed ID: 15710853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical analysis of 11 cases of juvenile dermatomyositis and polymyositis].
    Ito S; Miyamae T; Imagawa T; Katakura S; Mori M; Tomono J; Ibe M; Mituda T; Aihara Y; Yokota S
    Ryumachi; 1998 Dec; 38(6):785-92. PubMed ID: 10047716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Use of intravenous megadoses of methylprednisolone for treatment of dermatomyositis in children].
    Romicka AM
    Pediatr Pol; 1995 Mar; 70(3):243-8. PubMed ID: 8657493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The PRINTO evidence-based proposal for glucocorticoids tapering/discontinuation in new onset juvenile dermatomyositis patients.
    Giancane G; Lavarello C; Pistorio A; Oliveira SK; Zulian F; Cuttica R; Fischbach M; Magnusson B; Pastore S; Marini R; Martino S; Pagnier A; Soler C; Staņēvicha V; Ten Cate R; Uziel Y; Vojinovic J; Fueri E; Ravelli A; Martini A; Ruperto N;
    Pediatr Rheumatol Online J; 2019 May; 17(1):24. PubMed ID: 31118099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Juvenile dermatomyositis].
    Dressler F; Huppertz HI
    Z Rheumatol; 2006 Nov; 65(7):587-90, 592-4. PubMed ID: 17051362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of steroid pulse therapy on immunoglobulin-resistant Kawasaki disease.
    Furukawa T; Kishiro M; Akimoto K; Nagata S; Shimizu T; Yamashiro Y
    Arch Dis Child; 2008 Feb; 93(2):142-6. PubMed ID: 17962370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous pulse methylprednisolone treatment of juvenile dermatomyositis.
    Laxer RM; Stein LD; Petty RE
    Arthritis Rheum; 1987 Mar; 30(3):328-34. PubMed ID: 3566824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current management of juvenile dermatomyositis in Germany and Austria: an online survey of pediatric rheumatologists and pediatric neurologists.
    Hinze CH; Speth F; Oommen PT; Haas JP
    Pediatr Rheumatol Online J; 2018 Jun; 16(1):38. PubMed ID: 29925381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of methylprednisolone pulse therapy in polymyositis/dermatomyositis.
    Bolosiu HD; Man L; Rednic S
    Adv Exp Med Biol; 1999; 455():349-57. PubMed ID: 10599369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral versus intravenous corticosteroids in children hospitalized with asthma.
    Becker JM; Arora A; Scarfone RJ; Spector ND; Fontana-Penn ME; Gracely E; Joffe MD; Goldsmith DP; Malatack JJ
    J Allergy Clin Immunol; 1999 Apr; 103(4):586-90. PubMed ID: 10200005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of aggressive corticosteroid therapy in patients with juvenile dermatomyositis: a propensity score analysis.
    Seshadri R; Feldman BM; Ilowite N; Cawkwell G; Pachman LM
    Arthritis Rheum; 2008 Jul; 59(7):989-95. PubMed ID: 18576304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral prednisone taper following intravenous steroids fails to improve disability or recovery from relapses in multiple sclerosis.
    Perumal JS; Caon C; Hreha S; Zabad R; Tselis A; Lisak R; Khan O
    Eur J Neurol; 2008 Jul; 15(7):677-80. PubMed ID: 18459972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.